Bringing cell therapies to patients and accelerating the path to market for clean meat, denovoMATRIX deploys its modular, biomimetic coating technology to enable high performance cell culture. Now through the introduction of its first stem cell products, denovoMATRIX’ is aiming to accelerate the development and commercialization of cultivated meat and cell therapies.
denovoMATRIX will provide high-potency stem cells derived from adult human bone marrow, specifically mesenchymal stromal cells (MSCs), at a research-grade level. Using a unique isolation process, the premium cell line product denovoCELLS hMSC, is isolated and established from denonMATRIX using the isoMATRIX in combination with a completely serum-free process. While priced at a competitive value for customers, denovoMATRIX can offer the MSCs at a lower population doubling level than comparable products on the market.
“The availability of high potency stem cells at affordable prices is aimed at enabling researchers. Our efficient isolation technology allows us to translate these benefits to our customers.’’ explained Dr. Dejan Husman, CEO.
The potential for denovoCELLS hMSC to advanced expansion and differentiation potential while meeting the ISCT requirements for MSC identity, offers young and fast-growing stem cells. denovoMATRIX wants to support and empower scientists in the fields of basic and translational research as well as product development. denovoMATRIX serves customers in cell therapy, cultivated meat and pharmaceutical research with tools for supporting cell isolation, manufacturing, and differentiation.
Source: denovoMATRIX GmbH Press Release
While we have you…
We are continuously working to better optimize our content for you, our audience. Let us know how we’re doing by ticking the box below, or send us your feedback directly to firstname.lastname@example.org.